A Case of Vitiligo Combined With Systemic Lupus Erythematosus Treated With Tofacitinib
March 2024
in “
Clinical, cosmetic and investigational dermatology
”
TLDR Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.
This report discusses a unique case of a patient with vitiligo and systemic lupus erythematosus (SLE) who achieved complete repigmentation of the white macular rash after a 30-day treatment with tofacitinib, an oral JAK inhibitor. The treatment was effective and did not result in any adverse drug reactions, suggesting that JAK inhibitors like tofacitinib could be a promising new treatment option for vitiligo, especially in patients with concurrent autoimmune diseases.
